Skip to main content

Table 1 Clinical and LDCT data (n = 247)

From: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19

Clinical data All (n = 247)
Age (years)—mean ± SD 43 ± 15 [18–86]
Sex (male) 117/247 (47%)
Symptoms 230/247 (93%)
Cough 131/247 (53%)
Rhinitis 94/247 (38%)
Fever 40/247 (16%)
Anosmia 110/247 (45%)
Ageusia 102/247 (41%)
Dyspnea 68/247 (28%)
Chest pain 44/247 (18%)
Needed oxygen 7/247 (3%)
Desaturation 27/247 (11%)
Hospitalization 9/247 (4%)
Delay between first symptoms and chest CT (days)—mean ± SD 8 ± 4 [0–23]
Diabetes 12/247 (5%)
Hypertension 27/247 (11%)
Cancer status 9/247 (4%)
Cardiac disease 7/247 (3%)
LDCT data
 Dose-length product (mGy cm)—mean ± SD 39.8 ± 6.3
 Global score-mean ± SD 4.5 ± 6.5
 Normal LDCT 109/247 (44%)
 Exclusive peripheral abnormalities 98/247 (40%)
 Exclusive GGOs 102/247 (41%)
 Crazy paving pattern (GGOs + septal thickening) 16/247 (6%)
 GGOs + areas of consolidation 30/247 (12%)
  1. Clinical and LDCT data in the whole population. The qualitative variables are expressed as figures with percentages, and the continuous variables are expressed as the mean value ± DS
  2. LDCT low-dose computed tomography